共 12 条
- [1] ZS-9, a Novel Selective Potassium Trap, Rapidly Reduced Serum Potassium in Patients with Diabetes Treated for HyperkalemiaDIABETES, 2014, 63 : A296 - A296Rasmussen, Henrik S.Block, Geoffrey A.Lavin, Philip T.El-Shahawy, Mohamed A.Roger, Simon D.Packham, David K.Yang, AlexSingh, Bhupinder
- [2] Thermodynamic Energy Stability and In Vitro Potassium Exchange by ZS-9, a Novel Selective Cation Trap for Treatment of HyperkalemiaHYPERTENSION, 2014, 64Singh, BhupinderYang, AlexNuttall, MarkLow, JohnRasmussen, Henrik S.
- [3] ZS-9, A NOVEL SELECTIVE CATION TRAP, LEADS TO A RAPID AND PREDICTABLE RATE OF DECLINE IN SERUM POTASSIUM IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERKALEMIAJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A369 - A369Singh, BhupinderAsh, Stephen A.Lavin, Philip T.Yang, AlexRasmussen, Henrik S.
- [4] IN VITRO ION EXCHANGE CAPACITY AND SELECTIVITY OF ZS-9, A NOVEL, SELECTIVE CATION TRAP FOR THE TREATMENT OF HYPERKALEMIAAMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) : A115 - A115Yang, AlexLeon, AlejandroNuttall, MarkLow, John J.Rasmussen, Henrik S.
- [5] A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficientKIDNEY INTERNATIONAL, 2015, 88 (02) : 404 - 411Ash, Stephen R.Singh, BhupinderLavin, Philip T.Stavros, FionaRasmussen, Henrik S.
- [6] ZS-9, A NOVEL SELECTIVE CATION TRAP, DOES NOT SIGNIFICANTLY INCREASE SODIUM EXCRETION WHEN USED FOR THE TREATMENT OF HYPERKALEMIA IN PATIENTS WITH CKDAMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) : A103 - A103Singh, BhupinderAsh, Stephen R.Lavin, PhilipYang, AlexRasmussen, Henrik S.
- [7] Maintenance of Normokalemia with ZS-9 Once Daily in CHF Patients on RAAS Inhibitors: Subgroup Analysis of a Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Patients With HyperkalemiaHYPERTENSION, 2014, 64EI-Shahawy, Mohamed A.Singh, BhupinderRasmussen, Henrik S.Lavin, Philip T.Yang, AlexQunibi, Wajeh
- [8] Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Once-Daily ZS-9 for Treatment of Hyperkalemia: Maintenance of Serum K+ in Subgroup Analysis of Patients on RAAS TherapyHYPERTENSION, 2014, 64Singh, BhupinderRasmussen, Henrik S.Lavin, Philip T.Yang, AlexRoger, Simon D.
- [9] EXTENDED EFFICACY OF ZS-9 ONCE-DAILY IN A PHASE 3 MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH HYPERKALAEMIANEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 182 - 182Roger, Simon D.Rasmussen, Henrik S.Lavin, Philip T.Yang, AlexQunibi, Wajeh Y.
- [10] Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Once-Daily ZS-9 for Treatment of Hyperkalemia: Achievement and Maintenance of K plus in Subgroup Analysis of Patients with Heart Failure not on RAAS InhibitorsCIRCULATION, 2014, 130Singh, BhupinderRasmussen, Henrik S.Lavin, Philip T.Yang, AlexPackham, David K.